Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis

RC Founou, LL Founou, SY Essack - PloS one, 2017 - journals.plos.org
Introduction Despite evidence of the high prevalence of antibiotic resistant infections in
developing countries, studies on the clinical and economic impact of antibiotic resistance …

Estimating the burden of antimicrobial resistance: a systematic literature review

NR Naylor, R Atun, N Zhu, K Kulasabanathan… - … Resistance & Infection …, 2018 - Springer
Background Accurate estimates of the burden of antimicrobial resistance (AMR) are needed
to establish the magnitude of this global threat in terms of both health and cost, and to …

Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection

D Nie, Y Hu, Z Chen, M Li, Z Hou, X Luo, X Mao… - Journal of biomedical …, 2020 - Springer
Acinetobacter baumannii (A. baumannii) is an important opportunistic pathogen causing
serious nosocomial infections, which is considered as the most threatening Gram-negative …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

Quorum‐sensing system in Acinetobacter baumannii: a potential target for new drug development

K Saipriya, CH Swathi, KS Ratnakar… - Journal of applied …, 2020 - academic.oup.com
Acinetobacter baumannii causes several nosocomial infections and poses major threat
when it is multidrug resistant. Even pan drug‐resistant strains have been reported in some …

Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It

C Ma, S McClean - Vaccines, 2021 - mdpi.com
Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …

[HTML][HTML] Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic …

X Tan, H Chen, M Zhang, Y Zhao, Y Jiang… - Frontiers in cellular …, 2021 - frontiersin.org
Overuse of antibiotics in clinical medicine has contributed to the global spread of multidrug-
resistant bacterial pathogens, including Acinetobacter baumannii. We present a case of an …

Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients

S Karakonstantis, A Gikas, E Astrinaki… - Journal of Hospital …, 2020 - Elsevier
Summary Background Pandrug-resistant Acinetobacter baumannii (PDRAB) is increasingly
being reported as a nosocomial pathogen worldwide, but determining its clinical impact is …

Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent …

A Čiginskienė, A Dambrauskienė, J Rello… - Medicina, 2019 - mdpi.com
Background and objectives: High mortality and healthcare costs area associated with
ventilator-associated pneumonia (VAP) due to Acinetobacter baumannii (A. baumannii). The …

Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii

EHTT Jayathilaka, DC Rajapaksha… - International Journal of …, 2021 - mdpi.com
Acinetobacter baumannii is a serious nosocomial pathogen with multiple drug resistance
(MDR), the control of which has become challenging due to the currently used antibiotics …